Methods of identifying signaling modulators of the trimeric TNFa
AssigneeUcb Biopharma Srl
InventorsJames Philip O'Connell, John Robert Porter, Alastair Lawson, Boris Kroeplien, Stephen Edward Rapecki, Timothy John Norman, David James McMillan, Graham John Warrellow, Daniel Christopher Brookings, Rikki Peter Alexander
Life of this patent
Estimating the term…
Abstract
The invention is in the field of TNF signalling. Compounds have been identified which are capable of modulating signalling of TNF trimers through receptors. Methods of identifying such compounds are therefore provided. The compounds themselves have utility in therapy.
Claims5
A method of identifying a compound that binds to trimeric TNFα and modulates signalling of the trimeric TNFα through a TNF receptor, the method comprising determining the average number of receptors bound per trimer-compound complex in comparison with a control, wherein the average number of receptors bound per trimer-compound complex is determined by:
- (i) ion mobility mass spectrometry;
- (ii) size exclusion chromatography;
- (iii) Förster Resonance Energy Transfer;
- (iv) crystallography;
- or
- (v) a combination thereof, wherein:
- (a) the control comprises trimeric TNFα and TNF receptors in the absence of the compound, wherein a decrease in the average number of receptors bound per trimer-compound complex in comparison with the control identifies that the compound modulates signalling through the receptor;
- or
- (b) the control comprises trimeric TNFα and TNF receptors, and a compound which is known to modulate signalling of the trimers through the receptors and an equivalent average number of receptors bound per trimer-compound complex in comparison with the control, or decrease in the average number of receptors bound per trimer-compound complex in comparison with the control, identifies that the compound modulates signalling through the receptor.
Dependencies are inferred from the claim text.